Paolo Rivela

4PUBLICATIONS
14CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 21, 2024
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.

Gianluca Cavallaro, Anna Grassi, Chiara Pavoni

|Nov 25, 2023
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice.

Rita Tavarozzi, Giulia Zacchi, Daniela Pietrasanta

|Aug 03, 2022
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.

Lydia Scarfò, Silvia Heltai, Elisa Albi

|Apr 12, 2022
Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis.

Monia Marchetti, Paolo Rivela, Claudia Bertassello

Pageof 1

Frequent Collaborators

1 joint publications

Monia Marchetti

1 joint publications

Lydia Scarfò

1 joint publications

Luca Laurenti

1 joint publications

Eleonora Perotta